Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0011832936
Thu, 29.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Study
Cosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alopecia
29.06.2023 / 06:15 GMT/BST
Dublin, Ireland – June 29, 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced the beginning of th [ … ]
Thu, 29.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Study
Cosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alopecia
29.06.2023 / 06:15 GMT/BST
Dublin, Ireland – June 29, 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced the beginning of th [ … ]
Wed, 28.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Product Launch
Cosmo announces Cortiment® approval in Japan
28.06.2023 / 06:15 GMT/BST
Dublin, Ireland – 28 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its partner Ferring Pharmaceuticals (“Ferring”) has received the ap [ … ]
Wed, 28.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Product Launch
Cosmo announces Cortiment® approval in Japan
28.06.2023 / 06:15 GMT/BST
Dublin, Ireland – 28 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its partner Ferring Pharmaceuticals (“Ferring”) has received the ap [ … ]
Thu, 22.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Agreement
Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea
22.06.2023 / 06:15 GMT/BST
Dublin, Ireland & Seoul, Korea – 22 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Hyundai Pharmaceutical Co., Ltd [ … ]
Thu, 22.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Agreement
Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea
22.06.2023 / 06:15 GMT/BST
Dublin, Ireland & Seoul, Korea – 22 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Hyundai Pharmaceutical Co., Ltd [ … ]
Tue, 20.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Regulatory Approval
Cosmo Pharmaceuticals announces approval of Winlevi® in Canada
20.06.2023 / 06:15 GMT/BST
Dublin, Ireland – 20 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its partner Sun Pharmaceutical Industries Limited (Reuters: SUN.B [ … ]
Tue, 20.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Regulatory Approval
Cosmo Pharmaceuticals announces approval of Winlevi® in Canada
20.06.2023 / 06:15 GMT/BST
Dublin, Ireland – 20 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its partner Sun Pharmaceutical Industries Limited (Reuters: SUN.B [ … ]
Fri, 26.05.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): AGMEGM
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting
26.05.2023 / 16:30 GMT/BST
Dublin, Ireland – 26 May 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its shareholders approved all agenda items at today's a [ … ]
Fri, 26.05.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): AGMEGM
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting
26.05.2023 / 16:30 GMT/BST
Dublin, Ireland – 26 May 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its shareholders approved all agenda items at today's a [ … ]